| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3948226 | Gynecologic Oncology Reports | 2015 | 4 Pages |
Abstract
•Aggressive course and treatment resistance characterize ectopic human chorionic gonadotropin.•Recurrence of endometrial cancer with ectopic hCG was treated with brachytherapy and EMACO.•The serum hCG level can serve as a marker in tumors with ectopic hCG expression.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Regina Lee, Roland Pattillo, Mark Bouzyk, Gabriela Oprea-Ilies, Roland Matthews,